Chemotherapy for advanced testicular cancer

E. P. Fox, P. J. Loehrer

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Advanced testicular cancer is a model for a chemotherapeutically curable solid neoplasm. The current standard of therapy is cisplatin-based chemotherapy administered over three to four courses depending on the extent of the disease. The long-term sequelae are few. More recent studies have started to define the minimum therapy necessary for good-risk patients. Ongoing studies are evaluating more aggressive innovative therapies for high- risk patients.

Original languageEnglish (US)
Pages (from-to)1173-1187
Number of pages15
JournalHematology/Oncology Clinics of North America
Volume5
Issue number6
StatePublished - Jan 1 1991

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Chemotherapy for advanced testicular cancer'. Together they form a unique fingerprint.

  • Cite this